Alexion Pharma (ALXN)

101.24 -0.64 (0.63%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/23/20 *Est.)
- M&A (6/30/20 *Est)

Latest Headlines

Alexion Announces Appointment of First Chief Diversity Officer August 6, 2020 8:00 AM - BizWire Alexion Pharmaceuticals (ALXN) PT Lowered to $151 at Raymond James July 31, 2020 9:04 AM - StreetInsider Alexion Pharmaceuticals (ALXN) PT Raised to $155 at SunTrust July 31, 2020 7:10 AM - StreetInsider Alexion Pharmaceuticals (ALXN) PT Raised to $163 at SVB Leerink July 31, 2020 6:41 AM - StreetInsider Form S-8 ALEXION PHARMACEUTICALS, July 31, 2020 6:03 AM - SEC Filing William Blair Downgrades Alexion Pharmaceuticals (ALXN) to Market Perform July 31, 2020 4:30 AM - StreetInsider Alexion Pharmaceuticals (ALXN) PT Raised to $155 at SunTrust, Following Earnings July 30, 2020 3:52 PM - StreetInsider Alexion Pharmaceuticals (ALXN) PT Raised to $167 at JPMorgan, Following Earnings July 30, 2020 3:36 PM - StreetInsider Alexion Pharmaceuticals (ALXN) PT Raised to $120 at Stifel, Following Earnings July 30, 2020 3:26 PM - StreetInsider Alexion Pharmaceuticals (ALXN) PT Raised to $114 at Jefferies, Following Earnings July 30, 2020 3:11 PM - StreetInsider Alexion Pharmaceuticals (ALXN) PT Raised to $156 at Wedbush, Following Earnings July 30, 2020 1:41 PM - StreetInsider Form 10-Q ALEXION PHARMACEUTICALS, For: Jun 30 July 30, 2020 7:39 AM - SEC Filing Form 8-K ALEXION PHARMACEUTICALS, For: Jul 30 July 30, 2020 7:07 AM - SEC Filing Alexion Pharma (ALXN) Tops Q2 EPS by 52c, Raises FY Guidance July 30, 2020 6:32 AM - StreetInsider Alexion Reports Second Quarter 2020 Results July 30, 2020 6:30 AM - BizWire Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020 July 16, 2020 6:30 AM - BizWire Alexion pays $21 million resolving charges of breaking U.S. foreign corruption law: SEC July 2, 2020 12:20 PM - StreetInsider Alexion Pharma (ALXN) to Pay $21M to Settle with SEC over FCPA Violations July 2, 2020 8:58 AM - StreetInsider Alexion Pharma (ALXN) Completes Acquisition of Portola (PTLA) July 2, 2020 8:55 AM - StreetInsider SEC Charges Alexion Pharma (ALXN) With FCPA Violations July 2, 2020 8:55 AM - StreetInsider Form 8-K ALEXION PHARMACEUTICALS, For: Jul 02 July 2, 2020 8:54 AM - SEC Filing Alexion Completes Acquisition of Portola July 2, 2020 8:45 AM - BizWire ULTOMIRIS® (ravulizumab) Receives Marketing Authorization from European Commission for Adults and Children with Atypical Hemolytic Uremic Syndrome (aHUS) June 29, 2020 2:00 AM - BizWire Alexion Pharma (ALXN) Announces Phase 3 Study of Weekly Subcutaneous ULTOMIRIS in PNH Met Primary Endpoint June 24, 2020 9:13 AM - StreetInsider Alexion Announces Phase 3 Study of Weekly Subcutaneous ULTOMIRIS® (ravulizumab-cwvz) Met Primary Endpoint June 24, 2020 9:12 AM - BizWire Alexion Charitable Foundation Announces First Rare Belonging® Grants June 17, 2020 8:30 AM - BizWire Alexion to Present at the 2020 Bank of America Virtual Napa Biotech Conference June 17, 2020 6:30 AM - BizWire Form 4 ALEXION PHARMACEUTICALS, For: Jun 08 Filed by: Franchini Indrani Lall June 9, 2020 5:06 PM - SEC Filing Form 4 ALEXION PHARMACEUTICALS, For: Jun 08 Filed by: LAW ANNE-MARIE June 9, 2020 5:02 PM - SEC Filing Form 4 ALEXION PHARMACEUTICALS, For: Jun 08 Filed by: ORLOFF JOHN J June 9, 2020 5:00 PM - SEC Filing Form 4 ALEXION PHARMACEUTICALS, For: Jun 08 Filed by: Goff Brian June 9, 2020 4:59 PM - SEC Filing Alexion to Present at the 41st Annual Global Goldman Sachs Healthcare Conference June 4, 2020 6:30 AM - BizWire Form 8-K/A ALEXION PHARMACEUTICALS, For: May 29 June 3, 2020 5:24 PM - SEC Filing Alexion Pharmaceuticals (ALXN) PT Raised to $147 at Credit Suisse June 1, 2020 5:46 AM - StreetInsider Form 8-K ALEXION PHARMACEUTICALS, For: May 29 May 29, 2020 4:13 PM - SEC Filing Pre-Open Stock Movers 05/28: (PHAS) (TGI) (DLTR) (TOL) (ALXN) (HTZ) (TWTR) (More...) May 28, 2020 9:03 AM - StreetInsider Alexion Pharma (ALXN), Amgen (AMGN) Reach Soliris IPR Settlement May 28, 2020 8:19 AM - StreetInsider Form 8-K ALEXION PHARMACEUTICALS, For: May 19 May 19, 2020 4:57 PM - SEC Filing Form 4 ALEXION PHARMACEUTICALS, For: May 14 Filed by: BAKER FELIX May 18, 2020 6:58 PM - SEC Filing Form 4 ALEXION PHARMACEUTICALS, For: May 14 Filed by: Brennan David R May 18, 2020 5:23 PM - SEC Filing Form 4 ALEXION PHARMACEUTICALS, For: May 14 Filed by: Rummelt Andreas May 18, 2020 5:21 PM - SEC Filing Form 4 ALEXION PHARMACEUTICALS, For: May 14 Filed by: Mollen John T May 18, 2020 5:19 PM - SEC Filing Form 4 ALEXION PHARMACEUTICALS, For: May 14 Filed by: Reinsdorf Judith A May 18, 2020 5:18 PM - SEC Filing Form 4 ALEXION PHARMACEUTICALS, For: May 14 Filed by: COUGHLIN CHRISTOPHER J May 18, 2020 5:16 PM - SEC Filing Form 4 ALEXION PHARMACEUTICALS, For: May 14 Filed by: Nader Francois May 18, 2020 5:14 PM - SEC Filing Form 4 ALEXION PHARMACEUTICALS, For: May 14 Filed by: FRIEDMAN PAUL A May 18, 2020 5:13 PM - SEC Filing Form 4 ALEXION PHARMACEUTICALS, For: May 14 Filed by: Dunsire Deborah May 18, 2020 5:11 PM - SEC Filing Alexion Announces Upcoming Data Presentations at the Virtual 25th Congress of the European Hematology Association May 14, 2020 9:31 AM - BizWire Full Article List